mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.3 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |